Skip to content

Marketstatics

Menu
  • Home
  • About Us
  • Contact Us
Menu

Category: Pharmaceutical

HPO Inozyme Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Inozyme Pharma Market Size and Forecast The market for treatments targeting rare genetic disorders addressed by Inozyme Pharma, particularly ENPP1 Deficiency, is highly specialized but growing. This area falls under the broader…

Hyperimm Pertussis Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Hyperimm Pertussis Market Size and Forecast The global market for pertussis treatments and prevention, which includes hyperimmune globulin therapies (Hyperimm Pertussis) and vaccines, is expected to grow from USD 3.92 billion in…

Actinium-225 PSMA Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Actinium-225 PSMA Market Size and Forecast The Actinium-225 (Ac-225) market, which includes Ac-225 PSMA therapies, is a rapidly emerging segment of the radiopharmaceuticals sector, driven by the exceptional efficacy of alpha-emitting radionuclides…

SCLC Topotecan Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Topotecan in SCLC Market Size and Forecast Topotecan (Hycamtin) holds a steady, though relatively niche, position within the Small Cell Lung Cancer (SCLC) therapeutics market, primarily serving as a second-line or relapsed…

HF CVOT Data Drugs Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

HF CVOT Data Drugs Market Size and Forecast The global Heart Failure (HF) drugs market, particularly those supported by Cardiovascular Outcome Trial (CVOT) data, is a critical segment showing rapid expansion. The…

Lead-212 DOTATATE Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Lead-212 DOTATATE Market Size and Forecast Lead-212 DOTATATE (often referred to by commercial names like AlphaMedix™) belongs to the rapidly emerging targeted alpha therapy (TAT) market, specifically for somatostatin receptor-expressing neuroendocrine tumors…

ALK Alectinib Generics Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

ALK Alectinib Generics Market Size and Forecast The ALK Alectinib generics market is set for significant expansion following the patent expiry of the originator drug, Alecensa, expected around 2035. While the branded…

Dep Gepirone Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Gepirone Market Size and Forecast Gepirone (marketed as Exxua) is an extended-release formulation recently approved by the FDA in October 2023 for the treatment of Major Depressive Disorder (MDD). Its market introduction…

Integrin Tracers Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Integrin Tracers Market Size and Forecast The global Integrin Tracers market is a specialized, high-growth niche within nuclear medicine and molecular imaging, driven by their critical role in visualizing cancer, cardiovascular, and…

ROS1 Crizotinib Legacy Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

ROS1 Crizotinib Legacy Market Size and Forecast The ROS1 Crizotinib legacy market refers to the continuing use and economic presence of Crizotinib (XALKORI) as a first-generation targeted therapy for ROS1-fusion positive Non-Small…

Posts pagination

Previous 1 … 14 15 16 … 101 Next

Categories

  • Healthcare
  • Pharmaceutical
  • Uncategorized
©2025 Marketstatics | Design: Newspaperly WordPress Theme